PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsLung neoplasms
MeSH D008175 - lung neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012142:Respiratory tract neoplasms
0 Companies
0 Drugs
Success rate
D008171:Lung diseases
3 Companies
2 Drugs
$
Success rate
D008175: 
Lung neoplasms
62 Companies
27 Drugs
$
Success rate
D000086002:Malignant mesothelioma
1 Company
1 Drug
$
Success rate
D001984:Bronchial neoplasms
0 Companies
0 Drugs
Success rate
D010178:Pancoast syndrome
0 Companies
0 Drugs
Success rate
D047868:Pulmonary sclerosing hemangioma
0 Companies
0 Drugs
Success rate
D055613:Multiple pulmonary nodules
0 Companies
0 Drugs
Success rate
D002283:Bronchogenic carcinoma
0 Companies
0 Drugs
Success rate
D000077192:Adenocarcinoma of lung
0 Companies
0 Drugs
Success rate
D018202:Pulmonary blastoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareCarboplatin Carboplatin  2017-02-09   
Etoposide Etoposide  1996-03-14   
Doxorubicin Zolsketil pegylated  2022-05-31   
Cisplatin Cisplatin  2015-08-18   
Methotrexate Methotrexate  2007-04-30   
Alembic PharmaceuticalsCyclophosphamide Cyclophosphamide  2022-11-10   
Methotrexate Methotrexate  2024-06-03   
AllerganCarboplatin Carboplatin  2004-10-14   
Doxorubicin Doxorubicin  2014-06-27   
Etoposide Etoposide  1996-10-15   
Amneal PharmaceuticalsCyclophosphamide Cyclophosphamide  2018-05-25   
Doxorubicin Doxorubicin  2017-02-17   
Methotrexate Methotrexate  2017-12-22   
ANI PharmaceuticalsCyclophosphamide Cyclophosphamide  2018-03-19   
APP PharmaceuticalsVinblastine Vinblastine  1985-11-18   
Methotrexate Methotrexate  1985-10-11   
Ayana PharmaDoxorubicin Doxorubicin  2021-10-12   
AzurityMethotrexate Xatmep 2033-01-02 2017-04-25   
Barr PharmaceuticalsMethotrexate Methotrexate  1990-10-15   
Methotrexate Trexall  2001-03-21   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
76%
159/210
Phase 2
36%
109/300
Phase 3
30%
47/155
Approved: 15Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Accord Healthcare
Cisplatin
Allergan
Carboplatin,
Nepidermin
Amneal Pharmaceuticals
Methotrexate
Ayana Pharma
Doxorubicin,
Doxorubicin hydrochloride
Barr Pharmaceuticals
Methotrexate
Baxter
Doxorubicin,
Cyclophosphamide,
Doxorubicin hydrochloride,
Ifosfamide,
Mesna,
Vp16
Bristol Myers Squibb
Methotrexate,
Doxorubicin,
Doxorubicin hydrochloride,
Etoposide,
Benzocaine,
Docusate,
Transplatin,
Lutetium dotatate lu-177,
Albumin,
Antithrombin iii,
Sitravatinib,
Cilmostim,
Lucitanib,
Enoblituzumab,
Linrodostat,
Entinostat,
Epacadostat,
Rovalpituzumab tesirine,
Plinabulin,
Amrubicin,
Galunisertib,
Mesmulogene ancovacivec,
Ademetionine,
Vicriviroc,
Glutamic acid,
Tropisetron,
Doconexent,
Regramostim,
Taurine,
Molgramostim,
SOTIGALIMAB,
Sodium chloride,
Sodium lactate,
APRICOXIB,
Bevifimod,
CABIRALIZUMAB,
Doxecitine,
Nadide,
Nepidermin,
PEGDINETANIB,
URELUMAB,
Vilobelimab,
Vorolanib,
Microcrystalline cellulose,
Mrtx-849,
D-glutamate,
Deoxycytidine,
Corticoids,
Foster,
Nerofe,
Mk3475,
Q2w,
Al3810,
COM701,
Vp16,
Hiltonol,
Sagramostim,
Solumedrol,
Sbrt,
Tmz,
Arm1,
Beam,
Gemcis,
Pcd,
Std,
UCPVAX,
Arm2,
Bolus,
Docetaxol,
Monosialotetrahexosylganglioside,
Taxane,
Evidence,
Iclc,
Nvb
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use